Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23
Phase 32

Trial Status

Completed5
Terminated1

Role Distribution

Principal Investigator5
Other Roles1
PI Rate83%

Activity Timeline

Clinical Trials (6)

NCT01842165Phase 3Completed
177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
Gastroenteropancreatic Neuroendocrine Tumors
Principalinvestigator
NCT01843725Phase 1Completed
Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers
Metastatic Biliary CancersMetastatic Breast CancersMetastatic Colorectal Cancers+3 more
Principalinvestigator
NCT01929616Phase 2Completed
Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)
Advanced Chemorefractory Colorectal Adenocarcinoma
Studychair

Research Network

Collaboration Network

6 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vincent Donckier, MD, PHD

Erasme University Hospital

Related
1 trials

Shared therapeutic areas:

Carcinoma, HepatocellularLiver Cirrhosis

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score24%

Amélie Deleporte, MD

Jules Bordet Institute

Related
1 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score14%

Patrick Flamen, M.D., Ph.D.

Jules Bordet Institute

Related
2 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score14%

Ioannis Karfis, MD

Jules Bordet Institute

Related
1 trials

Shared therapeutic areas:

Gastroenteropancreatic Neuroendocrine Tumors

Worked with same sponsors:

Jules Bordet Institute
Collaborated on 1 trial
Similarity Score14%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularLiver CirrhosisColorectal Cancer
Similarity Score7%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerColorectal NeoplasmsCarcinoma, Hepatocellular
Similarity Score7%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerLiver Cirrhosis
Similarity Score7%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerColorectal Neoplasms
Similarity Score7%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Colorectal CancerColorectal Neoplasms
Similarity Score5%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal Cancer
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00199173Phase 3PrincipalInvestigator

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Colorectal NeoplasmSecondary Malignant Neoplasm of Liver
Completed
NCT01290926Phase 2PrincipalInvestigator

Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer

Colorectal Cancer
Completed
NCT01686880Phase 2PrincipalInvestigator

Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

Hepatocellular CarcinomaLiver Cirrhosis
Terminated
NCT01842165Phase 3PrincipalInvestigator

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs

Gastroenteropancreatic Neuroendocrine Tumors
Completed
NCT01843725Phase 1PrincipalInvestigator

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers

Metastatic Biliary CancersMetastatic Breast CancersMetastatic Colorectal Cancers+3 more
Completed
NCT01929616Phase 2StudyChair

Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)

Advanced Chemorefractory Colorectal Adenocarcinoma
Completed

All 6 trials loaded